# Pilot Study of Neoadjuvant Chemotherapy Combined With Immunotherapy and Multimodal Thermal Therapy for HER2-negative Breast Cancer

> clinical trial · VERIFIED · 2026-07-08

Status: COMPLETED · Sponsor: Fudan University · Condition: Breast Cancer Female

- Company: Fudan University
- Sector: Breast Cancer Female
- Primary source: https://clinicaltrials.gov/study/NCT06636591

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.